Cancer-Cooling Protein Can Stop Disease Spreading

New Treatment Pathway: Scientists reveal a potential treatment pathway for bowel cancer involving the immune system protein Ku70.

Protein Activation: Ku70 can be activated to combat bowel cancer when triggered by a drug cocktail, as per a study in Science Advances.

Prevalence of Bowel Cancer: Colorectal cancer is the third most common cancer in the U.S., with around 150,000 new cases annually.

Cancer-Related Deaths: Bowel cancer ranks as the second leading cause of cancer-related deaths in the U.S., with an estimated 53,000 deaths in 2024.

Importance of Early Detection: Survival rates for bowel cancer increase significantly when detected early.

Ku70 as Immune Biomarker: Ku70, an immune protein, is identified as a biomarker that predicts outcomes for individuals diagnosed with bowel cancer.

Potential Screening Method: Future bowel cancer screening could involve checking Ku70 levels in abnormal growths to guide screening frequency.